COVID-19 outcomes with anticancer treatments
There is a lot of ongoing research to understand the [...]
NHS rolls out ‘COVID-friendly’ cancer treatments
NHS chief executive, Sir Simon Stevens has announced the roll-out [...]
First-line treatment of patients with sarcomatoid kidney cancer
Sarcomatoid renal cell carcinoma (sRCC) is a rare and aggressive [...]
Survivorship and immune checkpoint inhibitors
In a study reported in the August issue of the [...]
The impact of COVID-19 pandemic on treatment for metastatic kidney cancer
A recent online survey involving 41 kidney cancer experts worldwide [...]
Funding approved for avelumab in combination with axitinib for untreated advanced kidney cancer
KCSN are formal consultants to NICE and part of the [...]
Encouraging results from two COVID-19 vaccine trials
Encouraging results have been published for two phase 1/2 COVID-19 [...]
Delay in cancer diagnosis during COVID-19 – what next?
This article in The Lancet describes the impact of the [...]
Combination of potential biomarkers may help predict response to immunotherapy in kidney cancer
Currently, it is difficult for clinicians to decide which patients [...]
Study shows steep rise in people waiting for cancer tests
The results from two studies have been released to show [...]
